Abbott to Buy Facet Biotech

March 9, 2010, 5:31 am by Wall Street Journal

Abbott Labs will bulk up its product pipeline with a $722 million deal for Facet Biotech, which had rebuffed overtures from development partner Biogen Idec.

Read the full article

More from Wall Street Journal

Helping a Loved One Fight Depression
Wall Street Journal : September 7, 2010, 12:02 pm
What can you do when your depressed or mentally ill loved one won't get treatment -- or denies he or she even has a problem?

Type-A Runners Learn to Pace Themselves
Wall Street Journal : September 6, 2010, 7:22 am
Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits.

Study Examines Sugar as Pain Reliever for Tots
Wall Street Journal : September 6, 2010, 6:51 am
In The Research Report, Jeremy Singer-Vine summarizes new medical findings on infant pain; circadian rhythms; lung cancer; cognitive exercise; migraine; low-carbohydrate diets; esophageal cancer and heart health.

Why It Hurts So Bad
Wall Street Journal : September 6, 2010, 5:53 am
Scientists are working on answering a basic question: What makes a punch painful?

New Clue in Heart Disease
Wall Street Journal : September 6, 2010, 5:47 am
Researchers have discovered a mysterious protein in cells of people as they age and are examining its role in heart disease.